Dr. Naim Joseph Salloum, MD

Dr. Salloum practices at Forrest General Hospital in Hattiesburg, Mississippi, part of Forrest County, MS.

Dr. Salloum's NPI, 1205870656, was assigned on June 16, 2006. Dr. Salloum holds Mississippi license 11650.

Dr. Salloum's primary practice is Forrest General Hospital, at 6051 US Highway 49, Hattiesburg, MS 39401 in Forrest County. The practice phone is (601) 288-7000.

Dr. Salloum's primary practice is Forrest General Hospital in Hattiesburg, Mississippi, part of Forrest County, MS. Dr. Salloum is also affiliated with Merit Health Wesley. The medical group on file is Forrest General Cancer Center. Dmand AI also links Dr. Salloum to 1 more hospital, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salloum practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Salloum's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Salloum is licensed in Mississippi.

CMS data shows 6,929 Medicare services from Dr. Salloum across 22 procedure codes in 2024, for 337 Medicare patients. Medicare paid $471,775 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 337 Medicare patients who saw Dr. Salloum in 2024. The largest group is 75 to 84, with 150 patients. 75% of them have cancer, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salloum's median patient age at 74, with 20% women.

In 2024, Dr. Salloum wrote 418 Medicare Part D claims for 162 patients. 80% of them were for generic drugs. CMS names the drug for 284 of them, across 13 drugs with 11 or more claims each, at $614,929 in total drug cost. In 2023, CMS named 281 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Salloum for performance year 2024, reported as part of a group. Dr. Salloum accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 98 general payments to Dr. Salloum from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $460.